NCT02546544View on ClinicalTrials.gov

Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

July 15, 2016

Study Completion Date

July 15, 2016

Conditions
Relapsed Ewing SarcomaRefractory Ewing Sarcoma
Interventions
DRUG

Linsitinib

Trial Locations (5)

40136

Istituti Ortopedici Rizzoli, Bologna

48149

Pediatric Hematology and Oncology, University Hospital Münster, Münster

Unknown

Universitè Lyon 1 Claude Bernard, Lyon

P.O. Box 9600

Department of Clinical Oncology, Leiden University Medical Center, Leiden

OX3 7LE

Oxford University Hospitals NHS Foundation Trust, Oxford

Sponsors

Collaborators (1)

Astellas Pharma Inc
All Listed Sponsors
collaborator

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

collaborator

European Commission

OTHER

collaborator

Astellas Pharma Inc

INDUSTRY

collaborator

Oxford University Hospitals NHS Trust

OTHER

lead

University of Oxford

OTHER